ATM and cancer: Our phosphoproteomic analysis followed by a validation study revealed alterations in the signaling networks and identified radiosensitizing molecular targets, including HDAC, ATM, and p38, in response to TAT with a 225Ac-labeled minigastrin analog in CCKBR-positive cancer cells.